Farallon Capital Management is a global multi-strategy hedge fund headquartered in San Francisco. With over 35 years of investment experience and $39 billion in capital under management, the firm focuses on a diverse range of investment strategies across various sectors and geographies. Farallon emphasizes alignment between its people, investors, and business partners.
The firm's portfolio includes notable companies such as Beam Therapeutics, Freenome, and Sea. Farallon has invested in various stages, from Series A to Post-IPO rounds, with a particular focus on Series C and D investments. The firm's approach is characterized by a strong emphasis on values, culture, and relationships, leveraging its extensive experience and reputation in the investment industry.
Farallon Capital Management - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments31
Current Portfolio Count20
Total Portfolio Exits5
Top Investment Stages
Series C7 (26.9%)
Post Ipo Equity6 (23.1%)
Series D6 (23.1%)
Series B5 (19.2%)
Series E2 (7.7%)
Stage Mix
Series C 27%Post Ipo Equity 23%Series D 23%Series B 19%Series E 8%
Concentration shown as share of disclosed investments by stage.
Farallon Capital Management - Classification
- Also Known As
- Farallon Capital Management, L.L.C.
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6720Investment Offices
- 6722Management Investment Offices, Open-end
Show 2 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- SIC
- 6000Depository Institutions